Skip to main content
. Author manuscript; available in PMC: 2014 Mar 21.
Published in final edited form as: J Neurochem. 2012 Aug 23;123(2):288–297. doi: 10.1111/j.1471-4159.2012.07875.x

Figure 7. A single or repeated METH administration did not alter striatal DAT localization 60 min following treatment.

Figure 7

Rats received either single or multiple injections of saline (single = 1 ml/kg, s.c.; multiple = 4 × 1 ml/kg/injection, 2-h intervals, s.c.) or METH (single = 15 mg/kg, s.c.; multiple = 4 × 7.5 mg/kg/injection, 2-h intervals, s.c.) and sacrificed 60 min following treatment (n = 6 per group). No changes in DAT immunoreactivity within the synaptosomal membrane (A, C) or vesicle (B, D) fractions were observed with either treatment paradigm. ‘DAT P’ indicates DAT peptide control lane.